FR2494112B1 - - Google Patents

Info

Publication number
FR2494112B1
FR2494112B1 FR8024568A FR8024568A FR2494112B1 FR 2494112 B1 FR2494112 B1 FR 2494112B1 FR 8024568 A FR8024568 A FR 8024568A FR 8024568 A FR8024568 A FR 8024568A FR 2494112 B1 FR2494112 B1 FR 2494112B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8024568A
Other languages
French (fr)
Other versions
FR2494112A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8024568A priority Critical patent/FR2494112B1/fr
Priority to BE1/10357A priority patent/BE891129A/en
Priority to PCT/FR1981/000148 priority patent/WO1982001649A1/en
Priority to AT0906481A priority patent/AT387517B/en
Priority to NL8120434A priority patent/NL8120434A/en
Priority to DE19813152519 priority patent/DE3152519C2/en
Priority to EP81903096A priority patent/EP0065531A1/en
Priority to IT25185/81A priority patent/IT1144948B/en
Publication of FR2494112A1 publication Critical patent/FR2494112A1/fr
Application granted granted Critical
Publication of FR2494112B1 publication Critical patent/FR2494112B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
FR8024568A 1980-11-19 1980-11-19 Expired FR2494112B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR8024568A FR2494112B1 (en) 1980-11-19 1980-11-19
BE1/10357A BE891129A (en) 1980-11-19 1981-11-16 NEW GALENIC FORM OF FENOFIBRATE, ITS PROCESS FOR OBTAINING ITS APPLICATION AS A MEDICINE
AT0906481A AT387517B (en) 1980-11-19 1981-11-18 METHOD FOR PRODUCING A PREPARATION OF PARA-AROYL-PHENOXY-ISOBUTTERIC ACID DERIVATIVES
NL8120434A NL8120434A (en) 1980-11-19 1981-11-18 NEW GALENIC FORM OF PHENOFIBRATE, METHOD OF PREPARATION AND MEDICINAL USE THEREOF.
PCT/FR1981/000148 WO1982001649A1 (en) 1980-11-19 1981-11-18 New galenic preparation of phenofibrate,method for the obtention thereof,its application as a medicine
DE19813152519 DE3152519C2 (en) 1980-11-19 1981-11-18 New fenofibrate ready-to-use product with delayed release of active ingredient
EP81903096A EP0065531A1 (en) 1980-11-19 1981-11-18 New galenic preparation of phenofibrate, method for the obtention thereof, its application as a medicine
IT25185/81A IT1144948B (en) 1980-11-19 1981-11-19 NEW GALENIC FORM OF PHENOFIBRATE, ITS PROCESS TO OBTAIN IT, ITS APPLICATION AS A MEDICINAL PRODUCT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8024568A FR2494112B1 (en) 1980-11-19 1980-11-19

Publications (2)

Publication Number Publication Date
FR2494112A1 FR2494112A1 (en) 1982-05-21
FR2494112B1 true FR2494112B1 (en) 1986-01-10

Family

ID=9248140

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8024568A Expired FR2494112B1 (en) 1980-11-19 1980-11-19

Country Status (8)

Country Link
EP (1) EP0065531A1 (en)
AT (1) AT387517B (en)
BE (1) BE891129A (en)
DE (1) DE3152519C2 (en)
FR (1) FR2494112B1 (en)
IT (1) IT1144948B (en)
NL (1) NL8120434A (en)
WO (1) WO1982001649A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
JPS60221078A (en) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd Granular product of useful microorganism powder and its preparation
IT1180507B (en) * 1984-06-29 1987-09-23 Roberto Valducci PROCEDURE FOR THE PREPARATION OF ETOFIBRATE OR SUBSTANCES OF EQUAL OR SIMILAR CHARACTERISTICS, IN MICROGUNULI-DELAY AND PRODUCT OBTAINED WITH SUCH PROCEDURE
FR2602423B1 (en) * 1986-08-08 1989-05-05 Ethypharm Sa PROCESS FOR THE PREPARATION OF A FENOFIBRATE-BASED MEDICINAL PRODUCT, OBTAINED BY THIS PROCESS
FR2627696B1 (en) * 1988-02-26 1991-09-13 Fournier Innovation Synergie NEW GALENIC FORM OF FENOFIBRATE
FR2737121B1 (en) * 1995-07-27 1997-10-03 Cl Pharma NEW GALENIC FORMULATIONS OF FENOFIBRATE AND THEIR APPLICATIONS
DE19608750A1 (en) * 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Process for the production of fenofibrate preparations
FR2758461A1 (en) * 1997-01-17 1998-07-24 Pharma Pass PHARMACEUTICAL COMPOSITION HAVING HIGH BIOAVAILABILITY AND PROCESS FOR PREPARING THE SAME
FR2758459B1 (en) 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
DE19858789A1 (en) 1998-12-18 2000-06-21 Bayer Ag Medicament combination of cerivastatin and fibrate, has additive effect in the treatment of lipid metabolism disorders, e.g. dyslipidemia or atherosclerosis
US6368622B2 (en) 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US6180138B1 (en) 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6383517B1 (en) 1999-01-29 2002-05-07 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
FR2795961B1 (en) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
FR2819720B1 (en) 2001-01-22 2004-03-12 Fournier Lab Sa NEW FENOFIBRATE TABLETS
AU2003263480A1 (en) * 2002-09-24 2004-04-19 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
CA2505521A1 (en) * 2002-11-22 2004-06-10 Meiji Seika Kaisha, Ltd. Granular composition and process for producing the same
ATE359777T1 (en) * 2002-12-17 2007-05-15 Abbott Gmbh & Co Kg PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATIC ACID AND PHYSIOLOGICALLY TOLERABLE SALTS AND DERIVATIVES THEREOF
EP1829541A1 (en) * 2002-12-17 2007-09-05 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
CA2531097C (en) * 2003-07-02 2012-10-09 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
EP1785133A1 (en) 2005-11-10 2007-05-16 Laboratoires Fournier S.A. Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (en) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド Oral testosterone undecanoate therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
FR1347413A (en) * 1963-01-29 1963-12-27 Italnysco S P A Broad-acting spherules or globules and method for their preparation
GB1415295A (en) * 1971-10-14 1975-11-26 Orchimed Sa Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form
GB1568837A (en) * 1975-10-10 1980-06-04 Squibb & Sons Inc Controlled release tablet
FR2313915A1 (en) * 1976-01-26 1977-01-07 Corneille Gilbert Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating
LU77353A1 (en) * 1977-05-16 1979-01-19
FR2432313A1 (en) * 1978-08-01 1980-02-29 Foulhoux Pierre Micro:granules contg. beta-histine - for controlled release and less side effects useful in treating Menieres syndrome

Also Published As

Publication number Publication date
NL8120434A (en) 1982-10-01
ATA906481A (en) 1988-07-15
FR2494112A1 (en) 1982-05-21
DE3152519C2 (en) 1990-11-22
AT387517B (en) 1989-02-10
EP0065531A1 (en) 1982-12-01
WO1982001649A1 (en) 1982-05-27
DE3152519T1 (en) 1983-12-29
IT8125185A0 (en) 1981-11-19
BE891129A (en) 1982-05-17
IT1144948B (en) 1986-10-29

Similar Documents

Publication Publication Date Title
FR2474310B1 (en)
FR2494112B1 (en)
FR2474883B1 (en)
FR2475641B1 (en)
FR2478872B1 (en)
FR2476899B1 (en)
FR2479619B1 (en)
DE3146354C2 (en)
FR2479681B3 (en)
DE3049581C2 (en)
FR2480477B1 (en)
DE3123419C2 (en)
FR2475966B3 (en)
DE3103461C2 (en)
FR2473382B1 (en)
FR2476916B1 (en)
FR2474796B1 (en)
FR2479958B1 (en)
FR2480316B1 (en)
FR2478981B1 (en)
FR2480768B1 (en)
FR2476747B1 (en)
FR2478910B1 (en)
FR2477094B1 (en)
FR2473456B3 (en)

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property